Bank of America’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Sell |
493,805
-318,237
| -39% | -$1.19M | ﹤0.01% | 4063 |
|
|
2025
Q1 | $2.24M | Buy |
812,042
+614,816
| +312% | +$1.7M | ﹤0.01% | 3845 |
|
|
2024
Q4 | $1.09M | Buy |
197,226
+138,661
| +237% | +$768K | ﹤0.01% | 4179 |
|
|
2024
Q3 | $488K | Sell |
58,565
-218,172
| -79% | -$1.82M | ﹤0.01% | 4672 |
|
|
2024
Q2 | $1.88M | Buy |
276,737
+238,373
| +621% | +$1.62M | ﹤0.01% | 3813 |
|
|
2024
Q1 | $252K | Sell |
38,364
-20,452
| -35% | -$134K | ﹤0.01% | 4947 |
|
|
2023
Q4 | $382K | Buy |
58,816
+30,993
| +111% | +$201K | ﹤0.01% | 4803 |
|
|
2023
Q3 | $140K | Sell |
27,823
-15,843
| -36% | -$79.7K | ﹤0.01% | 5229 |
|
|
2023
Q2 | $382K | Sell |
43,666
-4,285
| -9% | -$37.5K | ﹤0.01% | 4644 |
|
|
2023
Q1 | $568K | Buy |
47,951
+46,136
| +2,542% | +$546K | ﹤0.01% | 4555 |
|
|
2022
Q4 | $18.5K | Sell |
1,815
-5,911
| -77% | -$60.2K | ﹤0.01% | 5963 |
|
|
2022
Q3 | $46K | Sell |
7,726
-10,382
| -57% | -$61.8K | ﹤0.01% | 5867 |
|
|
2022
Q2 | $45K | Buy |
18,108
+10,884
| +151% | +$27K | ﹤0.01% | 6085 |
|
|
2022
Q1 | $21K | Sell |
7,224
-1,361
| -16% | -$3.96K | ﹤0.01% | 6699 |
|
|
2021
Q4 | $61K | Buy |
8,585
+3,453
| +67% | +$24.5K | ﹤0.01% | 6282 |
|
|
2021
Q3 | $53K | Buy |
5,132
+157
| +3% | +$1.62K | ﹤0.01% | 6129 |
|
|
2021
Q2 | $61K | Sell |
4,975
-4,512
| -48% | -$55.3K | ﹤0.01% | 5935 |
|
|
2021
Q1 | $208K | Buy |
+9,487
| New | +$208K | ﹤0.01% | 5356 |
|